Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-06-13

Clinical Trial Update: Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis [NA]

View source ↗

Summary

A clinical trial evaluating the effect of Saccharomyces cerevisiae on vulvovaginal candidiasis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saccharomyces cerevisiae (Saccharomyces cerevisiae)

Snippet

Sponsor: Lesaffre International | Conditions: Candidiasis, Vulvovaginal | NA | Status: TERMINATED